Marksans Pharma Limited is an international pharmaceutical company engaged in the research, development, manufacturing, and marketing of generic pharmaceutical formulations and over-the-counter (OTC) healthcare products. Established in 1992, the company has built a strong presence across regulated markets including the United Kingdom, the United States, Australia, and Europe, alongside expanding operations in emerging economies. Marksans specializes in tablets, capsules, liquids, ointments, and soft gel formulations across therapeutic categories such as pain management, cough and cold, gastrointestinal disorders, dermatology, and nutritional supplements. The company operates multiple manufacturing facilities that comply with stringent international regulatory standards, supporting exports to global healthcare markets. Through strategic acquisitions, product innovation, and investment in research and development, Marksans continues to strengthen its diversified portfolio and global distribution network. Its commitment to quality manufacturing, regulatory compliance, and affordable healthcare has established the company as a reliable supplier of generic and OTC medicines worldwide.
NSE: MARKSANS | BSE: 524404
Mumbai, Maharashtra, India
~2,500 employees
